Review of the MMSE as a Pre‐Screening Tool for Dementia in Clinical Trials
Pamela Voccia, Noel Fundora, Cyntauria Jones, Sheniba Pennyfeather Thomas, Andrew Boateng‐Poku, Olumide Otekalu · 2025
Read Review of the MMSE as a Pre‐Screening Tool for Dementia in Clinical Trials by Pamela Voccia, Noel Fundora, Cyntauria Jones, Sheniba Pennyfeather Thomas, Andrew Boateng‐Poku, Olumide Otekalu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710585.txt.
Description
Pamela Voccia and co-authors review how well a short memory test works as a first screen for dementia trials, in a 2025 paper. The test, the MMSE, is a standard prescreen in memory research. Raters at two sites in one research network collected scores from eighty-five hopeful trial volunteers. All reported memory concerns as their main complaint.
More than half still scored in the normal range on the test. For fifty-three people, a fuller clinical rating followed later. The review compares the quick scores with that deeper judgement. A prescreen that waves through many impaired volunteers, or blocks healthy ones, wastes effort on both sides. The findings inform how trial sites set their entry gates.
Catalog record
| CREATOR | Pamela Voccia, Noel Fundora, Cyntauria Jones, Sheniba Pennyfeather Thomas, Andrew Boateng‐Poku, Olumide Otekalu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |